导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.64% | 4035/4773 |
| 近一周 | -1.56% | 525/5462 |
| 近一月 | -8.14% | 4115/5421 |
| 近一季 | -17.06% | 4499/5209 |
| 近半年 | -22.83% | 4548/4920 |
| 近一年 | -8.68% | 3271/4366 |
| 近两年 | 32.77% | 2168/2954 |
| 近三年 | 4.35% | 1854/2253 |
| 成立以来 | 11.48% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.23% 558/4961 |
0.04% 3220/5312 |
- - |
- - |
| 2025 | 28.10% 1507/4813 |
-3.84% 3091/3635 |
0.43% 2656/4076 |
35.31% 996/4524 |
-1.96% 3049/4813 |
| 2024 | 3.30% 1934/3463 |
-2.23% 1337/2808 |
-7.54% 2096/3014 |
18.84% 919/3129 |
-3.85% 2398/3463 |
| 2023 | -27.41% 2006/2656 |
-2.65% 2034/2280 |
-5.06% 1361/2385 |
-13.91% 2167/2515 |
-8.77% 2308/2655 |
| 2022 | -22.45% 1069/2207 |
-14.70% 985/1919 |
14.43% 197/2016 |
-15.47% 1300/2113 |
-6.01% 1973/2208 |
| 2021 | 49.74% 5/1822 |
-4.78% 886/1255 |
30.47% 39/1330 |
19.30% 53/1466 |
1.04% 1019/1822 |
| 2020 | 53.61% 149/1250 |
-6.03% 449/1028 |
15.14% 514/1067 |
14.81% 253/1164 |
23.65% 40/1184 |
| 2019 | 20.25% 668/1092 |
25.71% 447/754 |
-9.99% 708/804 |
-1.45% 657/850 |
7.84% 389/918 |
| 2018 | -38.03% 605/834 |
- - |
- - |
- - |
-9.60% 152/691 |
| 2017 | 4.71% 385/714 |
- - |
- - |
- - |
- - |
| 2016 | -13.03% 316/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 鹏华中证环保产业指数(LOF)A VS. 长安沪深300非周期A(740101) |